Article
An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer.
Journal of cellular biochemistry - 1 Feb 2023
R Hephzibah Cathryn, Kumar S Udhaya, R Gnanasambandan, Naayanan P Jeyaprakash, Sathiyarajeswaren P, Devi M S Shree, K Satish Srinivas, Doss C George Priya
Abstract excerpt
In peripheral blood, cell-free DNA (cfDNA) contains circulating tumor DNA (ctDNA), which indicates molecular abnormalities in metastatic breast tumor tissue. The sequencing of cfDNA of Metastatic Breast Cancer (MBC) patients allows assessment of therapy response and noninvasive treatment. In the proposed study, clinically significant alterations in PIK3CA and TP53 genes associated with MBC resulting in a missense...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
